This study was conducted prospectively to evaluate the potential of interleukin (IL)-6, IL-8, and IL-10 for predicting bacteremia and to compare the levels of IL-6, IL-8, and IL-10 between patients during infection and patients after treatment. The gene discussed is IL6; the disease is infection.